Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07020546 · ClinicalTrials.gov registry record · NA
Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
A NA study of Infertility and in Vitro Fertilization, sponsored by Generation Next Fertility.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT07020546: Recruiting NA study of Infertility and in Vitro Fertilization, sponsored by Generation Next Fertility.
NCT07020546 is a NA study of Infertility and in Vitro Fertilization that is actively recruiting participants, run by Generation Next Fertility. The registered enrollment target is 180 participants, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07020546, a NA study of Infertility and in Vitro Fertilization, is actively recruiting participants, sponsored by Generation Next Fertility.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.
Primary Outcome
The number of high quality embryos that are created per cycle
Conditions Studied
Interventions
- PROCEDURE Ovarian Platelet-rich plasma (PRP) injections
Study Locations (1)
New York
- Generation Next Fertility - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-07-08 |
| Est. Completion | 2026-08-30 |
| Phase | NA |
What NCT07020546 shows while recruiting
NCT07020546 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower).
The record links to 4 conditions, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which Ovarian Platelet-rich plasma (PRP) injections is the first listed.
NCT07020546 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07020546 about?
NCT07020546 is a clinical study titled "Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score". Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.
What is the current status of trial NCT07020546?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-07-08. Estimated completion is 2026-08-30.
What conditions does trial NCT07020546 study?
This clinical trial studies the following conditions: Infertility, in Vitro Fertilization, Poor Ovarian Reserve, Embryo Growth Disorder.
What interventions are being tested in trial NCT07020546?
The interventions under investigation include: Ovarian Platelet-rich plasma (PRP) injections (PROCEDURE).
Who is sponsoring clinical trial NCT07020546?
This trial is sponsored by Generation Next Fertility, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07020546 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07020546's enrollment target sits among peer trials
180 44th of 74 higher than 31 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes
RECRUITING · NA
-
Testicular Tissue Cryopreservation in Children
RECRUITING · NA
-
Sex Selection of Human Spermatozoa
RECRUITING · NA
-
A Prospective Study of a Mosaic Embryo Transfer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI